EPT-10 PHASE I CLINICAL TRIAL OF HSV G207 ALONE OR WITH A SINGLE RADIATION DOSE IN CHILDREN WITH RECURRENT SUPRATENTORIAL BRAIN TUMORS (NCT02457845)

類似資料

• IMMU-08. PHASE I TRIAL (NCT02457845) SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF IMMUNOVIROTHERAPY WITH HSV G207 IN CHILDREN WITH PROGRESSIVE MALIGNANT SUPRATENTORIAL BRAIN TUMORS
  著者:: Friedman, Gregory, 等
  出版事項: (2018)
• Rationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors
  著者:: Waters, Alicia M., 等
  出版事項: (2017)
• PDCT-23. PROLIFERATION INDEX INFLUENCES INITIAL RESPONSE PATTERN OF PEDIATRIC HIGH-GRADE GLIOMAS TREATED WITH HSV-1 G207 ONCOLYTIC VIROTHERAPY
  著者:: Bag, Asim, 等
  出版事項: (2017)
• Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors
  著者:: Bernstock, Joshua D., 等
  出版事項: (2020)
• Stereotactic Placement of Intratumoral Catheters for Continuous Infusion Delivery of Herpes Simplex Virus -1 G207 in Pediatric Malignant Supratentorial Brain Tumors
  著者:: Bernstock, Joshua D., 等
  出版事項: (2018)